Generation and characterization of monoclonal antibodies against pathologically phosphorylated TDP-43
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0298080 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Paula Castellanos Otero und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, United States of America. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Frontotemporal Dementia, TDP-43 Proteinopathies. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NIA NIH HHS, Foundation for the National Institutes of Health.
Abstract (Originalsprache)
Inclusions containing TAR DNA binding protein 43 (TDP-43) are a pathological hallmark of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). One of the disease-specific features of TDP-43 inclusions is the aberrant phosphorylation of TDP-43 at serines 409/410 (pS409/410). Here, we developed rabbit monoclonal antibodies (mAbs) that specifically detect pS409/410-TDP-43 in multiple model systems and FTD/ALS patient samples. Specifically, we identified three mAbs (26H10, 2E9 and 23A1) from spleen B cell clones that exhibit high specificity and sensitivity to pS409/410-TDP-43 peptides in an ELISA assay. Biochemical analyses revealed that pS409/410 of recombinant TDP-43 and of exogenous 25 kDa TDP-43 C-terminal fragments in cultured HEK293T cells are detected by all three mAbs. Moreover, the mAbs detect pS409/410-positive TDP-43 inclusions in the brains of FTD/ALS patients and mouse models of TDP-43 proteinopathy by immunohistochemistry. Our findings indicate that these mAbs are a valuable resource for investigating TDP-43 pathology both in vitro and in vivo .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, United States of America.
- Neurobiology of Disease Graduate Program, Mayo Graduate School, Mayo Clinic College of Medicine, Rochester, Minnesota, United States of America.
- Department of Neurology, Mayo Clinic, Jacksonville, Florida, United States of America.
ORCID-Profile: Udit Sheth, Yong-Jie Zhang
Förderung
- NINDS NIH HHS
- NIA NIH HHS
- Foundation for the National Institutes of Health
- Mayo Foundation for Medical Education and Research
- Robert Packard Center for ALS Research, Johns Hopkins University
- Target ALS
Zitieren
APA
Castellanos Otero, P., Todd, T. W., Shao, W., Jones, C. J., Huang, K., Daughrity, L. M., Yue, M., Sheth, U., Gendron, T. F., Prudencio, M., Oskarsson, B., Dickson, D. W., Petrucelli, L., & Zhang, Y. J. (2024). Generation and characterization of monoclonal antibodies against pathologically phosphorylated TDP-43. PLOS ONE. https://doi.org/10.1371/journal.pone.0298080
Vancouver
Castellanos Otero P, Todd TW, Shao W, Jones CJ, Huang K, Daughrity LM, et al. Generation and characterization of monoclonal antibodies against pathologically phosphorylated TDP-43. PLOS ONE. 2024. doi:10.1371/journal.pone.0298080
BibTeX
@article{CastellanosOtero2024,
author = {Castellanos Otero, Paula and Todd, Tiffany W and Shao, Wei and Jones, Caroline J and Huang, Kexin and Daughrity, Lillian M and Yue, Mei and Sheth, Udit and Gendron, Tania F and Prudencio, Mercedes and Oskarsson, Björn and Dickson, Dennis W and Petrucelli, Leonard and Zhang, Yong-Jie},
title = {Generation and characterization of monoclonal antibodies against pathologically phosphorylated TDP-43},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0298080}
}
EUVIMED